Senescent cells harbour features of the cancer epigenome

Hazel A. Cruickshanks(Cancer Research UK Scotland Institute), Tony McBryan(Cancer Research UK Scotland Institute), David M. Nelson(Cancer Research UK Scotland Institute), Nathan D. VanderKraats(Washington University in St. Louis), Parisha P. Shah(California University of Pennsylvania), John van Tuyn(Cancer Research UK Scotland Institute), Taranjit Singh(Cancer Research UK Scotland Institute), Claire Brock(Cancer Research UK Scotland Institute), Greg Donahue(California University of Pennsylvania), Donncha S. Dunican(Institute of Genetics and Cancer), Mark E. Drotar(Cancer Research UK Scotland Institute), Richard R. Meehan(Institute of Genetics and Cancer), John R. Edwards(Washington University in St. Louis), Shelley L. Berger(California University of Pennsylvania), Peter D. Adams(Cancer Research UK Scotland Institute)
Nature Cell Biology
November 24, 2013
10.1038/ncb2879
Cited by 362

Abstract

Related Papers

Antibodies, a laboratory manual
|Biomedicine & Pharmacotherapy|1989|12.5k
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Zhenbang Chen, Lloyd C. Trotman, David R. Shaffer et al.|Nature|2005|2k
The epigenetic progenitor origin of human cancer
Andrew P. Feinberg, Rolf Ohlsson, Steven Henikoff|Nature Reviews Genetics|2005|1.9k
Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo
Florence Debacq‐Chainiaux, Jorge D. Erusalimsky, Judith Campisi et al.|Nature Protocols|2009|1.6k
Induction of Tumors in Mice by Genomic Hypomethylation
François Gaudet, John Hodgson, Amir Eden et al.|Science|2003|1.5k